Akèy › Limfòm selil B › Nebraska › Omaha
Etid klinik pou Limfòm selil B nan Omaha, NE
5 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Omaha (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Ap rekriteFaz 3
- Nebraska Cancer Specialists, Omaha
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Ap rekriteFaz 1/2
- University of Nebraska Medical Center, Omaha
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
Ap rekriteFaz 1
- University of Nebraska Medical Center, Omaha
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Ap rekriteFaz 3
- University of Nebraska Medical Center (UNMC), Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Ap rekriteFaz 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Etid Limfòm selil B nan lòt vil
- New York City, NY19 etid
- Houston, TX16 etid
- Chicago, IL12 etid
- Nashville, TN11 etid
- Philadelphia, PA11 etid
- Rochester, MN10 etid
- Baldwin Park, CA9 etid
- Milwaukee, WI9 etid
- Cleveland, OH9 etid
- Salt Lake City, UT8 etid
- Boston, MA8 etid
- Columbus, OH7 etid
Lòt etid nan Omaha
- Kansè pwostat27 etid
- Kansè Poumon ki pa ti selil24 etid
- Kansè nan tete22 etid
- Kansè kolorektal18 etid
- Kansè (tout kalite)18 etid
- Myelom Miltip16 etid
- Limfòm Non-Hodgkin14 etid
- Kansè ovè14 etid
- Kansè pankreyas14 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak13 etid
- Kansè Metastatik13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.